SPRB CIK: 1683553

Spruce Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−35.9
FY22:
−41.7
FY23:
−33.3
FY24:
−56.0
FY25:
−33.3
Change from FY21 to FY24
millions USD
FY21:
−79.2
FY22:
23.7
FY23:
55.8
FY24:
0
FY25:
–
Change from FY21 to FY25
millions USD
FY21:
0.64
FY22:
−0.24
FY23:
49.1
FY24:
−1.62
FY25:
43.5
(positive)
Change from FY21 to FY24
millions USD
FY21:
−36.0
FY22:
−41.7
FY23:
−33.3
FY24:
−56.0
FY25:
–

All amounts in millions USD Data source:SEC EDGAR